Currently Available Funding Opportunities / Requests for Proposals (RFPs):
Drug Repurposing Clinical Trials to Impact Blood Cancers: for clinical repurposing trials testing repurposed drugs in any blood cancer from anywhere in the world – accepting budgets of up to $75,000. PROPOSAL SUBMISSIONS DUE MAY 6, 2022.
Repurposing Research to Address Diversity, Equity and Inclusion (DEI) in the Greater Chicago Area: for clinical repurposing trials from Chicagoland research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $100,000. PROPOSAL SUBMISSIONS DUE JUNE 6, 2022.
US Based Clinical Repurposing Trials to Address Diversity, Equity and Inclusion (DEI): for clinical repurposing trials in any disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000. PROPOSAL SUBMISSIONS DUE JUNE 6, 2022.
CureAccelerator Live! for Diversity, Equity and Inclusion (DEI) in Rare Diseases: for clinical repurposing trials in any rare disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000. PROPOSAL SUBMISSIONS DUE JUNE 6, 2022.
ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): for clinical repurposing trials in any disease led by an underserved researcher in any LMIC, as defined by the World Bank – accepting budgets of up to $50,000. PROPOSAL SUBMISSIONS DUE JUNE 20, 2022.